Download
protocol
303kb

pdf?

Abstract for BDNF E_max^® ImmunoAssay System

The BDNF E_max^® ImmunoAssay System is designed for the sensitive and specific detection of BDNF in an antibody sandwich format. In this format, flat-bottom 96-well plates are coated with Anti-BDNF Monoclonal Antibody (mAb) to bind soluble BDNF. The captured BDNF binds the second, specific, BDNF polyclonal antibody (pAb). After washing, the amount of specifically bound pAb is detected using a species-specific anti-IgY antibody conjugated to horseradish peroxidase (HRP) as a tertiary reactant. Unbound conjugate is removed by washing, and following an incubation with a chromogenic substrate, color change is measured. The amount of BDNF in the test solution is proportional to the color generated in the oxidation-reduction reaction. This system can be used to quantitate BDNF in tissue culture supernatants, plasma, serum, urine and tissue extracts.

The BDNF E_max^® ImmunoAssay System offers several benefits:

• Specificity: Specific detection of BDNF; typically less than 3% cross-reactivity with other related neurotrophic factors (NGF, NT-3 and NT-4) at 100ng/ml.
• Sensitivity: Detects a minimum of 15.6pg/ml of BDNF.
• Flexibility: Available in sizes for five or two 96-well ELISA plates; can configure plates as desired.
• High Value: Optimized reagents and protocol.

Protocols
Index

Part# TB257
Printed in USA. Revised 6/06.
Instructions for Use of Products G7610 & G7611: Request this protocol.

Printed publications disclaimer.